Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M

After a series of trials and tribulations, Ventyx Biosciences has received a $27 million boost from Sanofi, money that is expected to extend the biotech’s cash runway into the second half of 2026.